Currently, only three cholinesterase inhibitors such as donepezil, galantamine, rivasigmine and a patial NMDA receptor antagonist, memantine, are the Food and Drug Administration (FDA) approved drugs to treat AD. This evidence concerns the gene BCHE and Alzheimer disease.